Please select the option that best describes you:
Topics:
Neurology • Vascular Neurology
What are your top takeaways from ISC 2025?
Answer from: at Academic Institution
We had hoped that medium-sized vessel occlusions (MeVOs) would respond to endovascular thrombectomy (EVT) as do large vessel occlusions (LVOs), but several trials show a lack of benefit of current EVT technology for MeVOs. Patients with MeVOs (and more distal occlusions) remain a target for findin...
Sign in or Register to read more
Answer from: at Academic Institution
EVT treatment for Medium Vessel Occlusion (MeVO) – ISC 2025 presentation of 3 trialsIn three trials that tackled the issue of extension of EVT to acute ischemic stroke due to more distal vessel occlusions, EVT was not better and possibly slightly harmful, as compared to the best medical care. ...
Answer from: at Community Practice
A contrarian answer, but I stand by it. My takeaway was that our research and efforts continue to focus on the wrong problems.
Since the 2015 thrombectomy trials, there have been no breakthroughs in stroke care of comparable benefit. We keep reshuffling the same therapies or refining them, re...